background
emerg
reemerg
respiratori
pathogen
repres
increas
threat
public
health
etiolog
determin
outbreak
gener
reli
clinic
inform
occasion
accompani
tradit
laboratori
molecular
serolog
test
often
limit
test
lead
inconclus
find
arm
forc
research
institut
medic
scienc
afrim
collect
nasopharyng
specimen
acut
influenzalik
ill
ili
patient
five
countri
southsouth
east
asia
three
hundr
twentyfour
sampl
found
neg
influenza
viru
screen
realtim
rtpcr
cellbas
cultur
techniqu
demonstr
potenti
viral
infect
evid
cytopath
effect
cpe
sever
cell
line
object
assess
whether
whole
genom
nextgener
sequenc
wgng
togeth
convent
molecular
assay
use
reveal
etiolog
influenza
neg
cpe
posit
specimen
studi
design
supernat
cpe
posit
cell
cultur
group
pool
contain
supernat
per
pool
three
wgng
run
perform
supernat
pool
sequenc
read
use
identifi
posit
pool
contain
viral
pathogen
individu
sampl
posit
pool
confirm
qrtpcr
rtpcr
pcr
sanger
sequenc
cpe
cultur
origin
clinic
specimen
asia
epicent
emerg
divers
respiratori
pathogen
repres
major
global
public
health
threat
accur
molecular
identif
respiratori
pathogen
vital
decisionmak
tool
public
health
offici
health
care
provid
unfortun
tradit
laboratori
techniqu
allow
broad
detect
viral
pathogen
routin
surveil
nextgener
sequenc
ng
power
tool
detect
emerg
reemerg
pathogen
obtain
inform
frequenc
intrahost
genet
variat
virolog
respons
treatment
ng
util
studi
commonli
circul
respiratori
virus
novel
virus
found
vector
anim
human
addit
whole
genom
ng
wgng
util
identifi
virus
diagnost
clinic
virolog
occasion
appli
parallel
standard
diagnost
assay
arm
forc
research
institut
medic
scienc
afrim
conduct
routin
acut
respiratori
ill
surveil
countri
southsouth
east
sse
asia
nepal
bhutan
thailand
cambodia
philippin
nasal
andor
oropharyng
swab
univers
transport
media
utm
collect
individu
seek
medic
care
acut
influenzalik
ill
ili
specimen
test
influenza
viru
ifv
rrtpcr
ifv
neg
specimen
sent
cellbas
cultur
isol
produc
cpe
neg
common
respiratori
viru
serolog
test
suggest
presenc
uncommon
respiratori
virus
cultur
sought
determin
could
identifi
pathogen
cpe
posit
sampl
despit
sampl
test
neg
use
antibodi
panel
common
respiratori
sampl
inform
obtain
use
improv
current
molecular
detect
protocol
incorpor
routin
surveil
clinic
diagnosi
investig
whether
wgng
use
uncov
etiolog
ifv
neg
cpe
posit
specimen
util
illumina
miseq
platform
conjunct
tradit
molecular
assay
viral
isol
ifv
rrtpcr
neg
show
cpe
posit
pool
sequenc
wgng
ng
sequenc
util
identifi
posit
pool
contain
viral
pathogen
pcr
sanger
sequenc
perform
individu
posit
pool
identifi
presenc
specif
viral
genotyp
posit
specimen
nasal
andor
oropharyng
swab
utm
copan
diagnost
inc
california
usa
collect
ili
surveil
site
sse
asia
surveil
sampl
collect
nepal
bhutan
thailand
cambodia
philippin
protocol
approv
institut
review
board
host
countri
institut
walter
reed
armi
institut
research
wrair
respiratori
specimen
neg
ifv
rrtpcr
underw
viral
isol
madindarbi
canin
kidney
mdck
cell
fig
cultur
supernat
cpe
posit
cultur
test
hemagglutin
inhibit
hai
ifv
indirect
fluoresc
antibodi
ifa
respiratori
syncyti
viru
rsv
ifv
ifv
b
human
adenoviru
hadv
human
parainfluenza
hpiv
cpe
posit
hai
ifaneg
supernat
select
test
wgng
supernat
cpe
posit
group
pool
contain
supernat
per
pool
base
countri
origin
year
initi
collect
cell
line
use
isol
tabl
equal
volum
cpe
posit
supernat
pool
make
total
volum
viru
enrich
step
includ
remov
host
cell
viru
concentr
step
appli
describ
previous
qiaamp
viral
rna
extract
kit
qiagen
ca
usa
use
viral
nucleic
acid
extract
nanodrop
wilmington
de
usa
agil
agil
technolog
ca
usa
util
quantifi
determin
qualiti
dna
rna
od
od
valu
truseq
lt
rna
sampl
prepar
conduct
follow
manufactur
instruct
describ
briefli
rna
heatfrag
follow
doubl
strand
cdna
synthesi
life
technolog
ny
usa
adapt
ligat
dna
quantiti
qualiti
control
valid
monitor
agil
qubit
fluoromet
life
technolog
ny
usa
rrtpcr
appli
biosystem
ca
usa
three
run
poolsrun
conduct
illumina
miseq
reagent
accord
manufactur
protocol
qualiti
control
sequenc
read
done
previous
describ
addit
step
use
novel
pathogen
find
fig
identif
individu
virus
pool
perform
follow
viral
genom
quantif
conduct
de
novo
assembl
sequenc
read
contig
consensu
sequenc
assembl
sequenc
read
triniti
follow
identif
contig
genbank
blastn
ii
de
novo
assembl
metaidba
follow
blast
complet
genom
sequenc
data
base
novel
pathogen
classif
follow
analysi
procedur
blastx
align
nonredund
nr
protein
databas
describ
previous
cutoff
kb
greater
contig
length
undetect
similar
refer
realtim
rtpcr
rtpcr
pcr
use
confirm
wgng
result
cpe
cultur
clinic
specimen
tabl
display
pcr
rtpcr
primer
sequenc
use
confirm
wgng
result
panev
rtpcr
result
confirm
sanger
sequenc
aitbiotech
pte
ltd
compani
singapor
access
number
sequenc
genbank
describ
tabl
small
subset
sampl
previous
publish
zhou
et
al
determin
genet
variat
relationship
refer
virus
phylogenet
tree
construct
use
seaview
gtrgi
paramet
calcul
mega
v
routin
ili
surveil
sse
asia
approxim
respiratori
specimen
collect
found
posit
ifv
rrtpcr
specimen
found
neg
fig
approxim
ifv
rrtpcr
neg
specimen
cultur
found
induc
cpe
posit
either
mdck
cell
total
cpe
posit
cultur
neg
standard
respiratori
hai
ifa
assay
cultur
sampl
per
pool
pool
total
distinct
pool
sequenc
wgng
identifi
viral
agent
present
supernat
follow
flow
diagram
illustr
fig
total
million
sequenc
read
gener
sequenc
run
select
sequenc
read
score
remov
background
sequenc
million
sequenc
read
remain
analys
sequenc
align
use
blastn
ncbi
nt
databas
identifi
viral
sequenc
pool
tabl
pool
cambodia
philippin
philippin
yield
sequenc
read
identifi
host
background
viral
pathogen
blastn
ncbi
nt
databas
sequenc
read
align
found
common
pool
addit
viral
sequenc
detect
pool
includ
mump
viru
muv
enteroviru
ev
coxsackieviru
cv
echoviru
e
human
rhinoviru
hrv
ifv
ifv
b
hpiv
human
adenoviru
hadv
human
coronaviru
hcov
human
metapneumoviru
hmpv
verifi
pool
result
use
convent
pcr
rtpcr
abl
confirm
wgng
result
case
tabl
shade
cell
discrep
occur
philippin
pcrrtpcr
test
fail
corrobor
presenc
virus
detect
wgng
pathogen
identif
made
wgng
pcr
three
pool
tabl
ital
letter
cultur
supernat
made
pool
test
pathogenspecif
pcr
rtpcr
rrtpcr
valid
wgng
find
quantifi
percentag
sampl
within
pool
virus
present
tabl
two
hundr
thirtyon
individu
sampl
posit
use
least
one
pathogenspecif
pcr
test
verifi
pathogen
identifi
ng
pool
sampl
tabl
approxim
posit
sampl
respiratori
pathogen
cv
common
respiratori
virus
found
present
posit
sampl
follow
e
found
sampl
ev
hrv
muv
hmpv
hcov
found
lesser
frequenc
tabl
two
sampl
posit
panenteroviru
panev
pcr
could
type
appear
tabl
panev
posit
also
found
respiratori
virus
fail
identifi
origin
screen
ifva
hadv
due
mismatch
primer
sequenc
fig
nonrespiratori
viru
common
viru
found
individu
supernat
present
sampl
tabl
least
sampl
appear
coinfect
agent
commonli
copres
enterovirus
one
sampl
collect
philippin
contain
hcov
strain
coinfect
addit
standard
molecular
procedur
conduct
select
sampl
result
valid
presenc
identifi
pathogen
clinic
specimen
cpe
cultur
major
clinic
specimen
deplet
unavail
confirm
test
seventyon
ev
posit
coinfect
sampl
sampl
nepal
bhutan
thailand
cambodia
philippin
subtyp
within
ev
genu
util
gtrgi
model
maximum
likelihood
tree
fig
use
sanger
sequenc
obtain
pcr
amplicon
previous
describ
posit
panev
sampl
found
cv
five
subtyp
enteroviru
genu
hrv
speci
c
found
one
countri
se
asia
genet
distanc
among
sampl
serotyp
found
countri
less
data
shown
one
case
detect
sampl
collect
thailand
seek
viral
pathogen
identif
contig
blastn
ncbi
nt
databas
pool
tabl
confirm
individu
sampl
pcr
rtpcr
rrtpcr
character
enteroviru
genu
panev
pcrleft
side
dark
grey
column
individu
cpe
sampl
obtain
phylogenet
analysi
sequenc
fig
total
number
sampl
gray
highlight
column
equal
number
panev
column
bold
letter
confirm
present
pathogen
previous
identifi
pool
wgng
asterisk
indic
except
case
pathogen
identifi
differ
indic
pool
unlin
letter
demonstr
sampl
contain
mismatch
sequenc
primer
rrtpcr
bind
tabl
summari
pathogen
identifi
case
still
unclear
etiolog
collect
routin
respiratori
surveil
illustr
fig
analys
found
frequent
viru
present
supernat
follow
ev
genu
common
respiratori
virus
agreement
observ
thailand
report
zhou
et
al
frequenc
posit
sampl
like
due
exacerb
exist
infect
caus
common
respiratori
infect
patient
subsequ
viral
shed
upper
respiratori
track
time
sampl
collect
individu
infect
routin
describ
asymptomat
subclin
estim
seropreval
se
asia
asia
virus
ev
genu
common
respiratori
pathogen
identifi
nine
sampl
thailand
sequenc
individu
confirm
present
ident
enteroviru
serotyp
sequenc
despit
spread
global
detect
surveil
studi
enrol
adult
age
group
studi
limit
sampl
size
detect
similar
rang
enteroviru
serotyp
cv
cv
cv
se
asian
countri
recent
studi
thailand
serotyp
identifi
outsid
thailand
strain
genet
distanc
thai
serotyp
suggest
tempor
spatial
structur
thai
broadli
se
asian
ev
popul
thu
may
indic
region
circul
ev
lineag
viral
traffic
countri
se
asia
overal
studi
demonstr
wgng
pool
cultur
supernat
use
tool
identifi
viral
pathogen
clinic
isol
howev
identif
pathogen
sampl
yield
low
sequenc
read
requir
addit
test
control
data
tabl
show
total
sequenc
read
without
subtract
background
sequenc
neg
control
experi
low
sequenc
read
sever
sampl
like
gener
combin
cross
talk
among
neighbor
sequenc
sampl
contamin
barcod
carri
previou
run
specif
exampl
philippin
pool
contain
sequenc
read
ident
philippin
pool
perform
next
librari
prepar
addit
three
pool
detect
host
background
viral
pathogen
possibl
due
low
viral
load
virus
grow
cultur
misidentifi
morpholog
cultur
identifi
cpe
posit
wgng
pool
cultur
provid
comprehens
inform
sampl
unclear
etiolog
routin
respiratori
assay
due
limit
studi
subset
sampl
select
sequenc
individu
ident
pathogen
sequenc
individu
agreement
result
pool
sampl
addit
wgng
pool
shown
contain
viral
pathogen
identifi
use
genbank
nt
databas
broken
individu
sampl
abl
confirm
presenc
respiratori
virus
individu
sampl
wgng
significantli
increas
valid
data
inform
addit
standard
respiratori
assay
furthermor
wgng
bioinformat
analysi
abl
identifi
viral
pathogen
pool
cultur
contain
sampl
potenti
make
method
time
labor
cost
effect
procedur
allow
screen
larger
number
sampl
practic
applic
surveil
clinic
studi
howev
sensit
detect
procedur
may
limit
mainli
pool
cpe
posit
cultur
test
oppos
individu
sequenc
primari
specimen
without
take
consider
sampl
detect
approxim
sampl
pool
remain
unknown
etiolog
wgng
bioinformat
data
analysi
fig
potenti
like
signific
limit
work
cell
line
select
viru
isol
limit
two
cell
line
may
curtail
type
virus
abl
isol
identifi
moreov
antibiot
requir
maintain
mdck
cultur
may
also
favor
growth
certain
virus
other
despit
use
tool
screen
viral
pathogen
wgng
pool
cultur
may
suffer
low
resolut
pathogen
identif
also
pathogen
discoveri
wgng
util
random
amplif
also
amplifi
host
genom
increas
complex
task
identifi
pathogen
gener
present
low
abund
clinic
specimen
cultur
long
sequenc
read
high
depth
coverag
doc
optim
identifi
divers
type
virus
variou
type
clinic
specimen
novel
pathogen
discoveri
would
requir
appli
advanc
sampl
prepar
higher
capac
host
cell
remov
procedur
directli
primari
clinic
specimen
effici
pathogen
discoveri
bioinformat
pipelin
summari
wgng
pool
sampl
provid
advantag
screen
tool
complement
standard
assay
use
surveil
diagnost
process
wgng
requir
predefin
target
identif
specif
pathogen
base
clinic
present
addit
wgng
broaden
array
magnitud
complex
pathogen
detect
sinc
limit
pathogenspecif
primer
probe
sequenc
requir
wgng
updat
primer
probe
sequenc
use
cultur
isol
continu
howev
technolog
provid
complex
result
requir
care
sampl
prepar
power
sequenc
exhaust
data
analysi
wellplan
bioinformat
pipelin
larg
databas
pathogen
identif
arm
forc
health
surveil
center
global
emerg
infect
surveil
respons
system
afhscgei
materi
review
walter
reed
armi
institut
research
object
present
andor
public
opinion
assert
contain
herein
privat
view
author
constru
offici
reflect
true
view
depart
armi
depart
navi
depart
defens
